MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.800
-0.080
-2.78%
After Hours: 2.800 0 0.00% 16:10 12/05 EST
OPEN
2.950
PREV CLOSE
2.880
HIGH
2.990
LOW
2.790
VOLUME
158.36K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
1.430
MARKET CAP
281.15M
P/E (TTM)
-3.1135
1D
5D
1M
3M
1Y
5Y
1D
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 2d ago
Weekly Report: what happened at ACIU last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at ACIU last week (1117-1121)?
Weekly Report · 11/24 09:34
Weekly Report: what happened at ACIU last week (1110-1114)?
Weekly Report · 11/17 09:34
AC Immune SA to Present at Jefferies London Healthcare Conference
Reuters · 11/11 12:00
Weekly Report: what happened at ACIU last week (1103-1107)?
Weekly Report · 11/10 09:33
AC Immune Price Target Maintained With a $8.00/Share by BTIG
Dow Jones · 11/04 17:11
BTIG Reiterates Buy on AC Immune, Maintains $8 Price Target
Benzinga · 11/04 17:02
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.